THMO

ThermoGenesis Holdings (THMO)

About ThermoGenesis Holdings (THMO)

ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, CAR-Txpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.

Details

Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.38
52 Week Low
$0.00
Market cap
0
Dividend yield
0.00%
Volume
2
Avg. volume
26
P/E ratio
.00

ThermoGenesis Holdings News

Details

Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.38
52 Week Low
$0.00
Market cap
0
Dividend yield
0.00%
Volume
2
Avg. volume
26
P/E ratio
.00